From Ozestock post 5948:
# Valuations and what the market is prepared to pay.
1. Post 5920 gives some share valuations. At present we have $88 mill tax losses to come and there will be more by June 30.
So, I am ignoring tax for at least the first year and there may not be any tax for the second year either. That should give NRT a very good start.
2. Year 1 to start with a positive Announcement on the receipt of defensible Isoflavone Patents and a Commercial Agreement on NV07a.
The numbers I gave to start from those dates. Most posters will accept that both will take place this year.
3. Share valuation and P/E.
In the cases below a P/E of 20 was applied-see post 5920:
3.1 Ignoring Cash, NV04 and some other prospective drugs, the valuation: $12.05.
3.2 Ignoring the Phenox trials, NV04 and other prospective drugs, as well as cash, then the share valuation is $9.55.
However, the market may want to apply a P/E of 15 instead; then the market value in 3.1 becomes: $9.03 and in 3.2 it will be $7.16.
The market may also decide to apply a P/E of 15 and discount these results say by 35%. The market values then become $5.87 and $4.65.
It is possible that the market will discount by an alarming 50% and maintain a P/E of 15.
The market values will then be $4.51 and $3.58( without trials etc).
Provided the Isoflavones Patents are issued and deemed defensible, then a share price of $3.58 is a conservative one IMHO.
So even if a very close estimate of the share valuation were made then the market will still value the stock as it sees fit. And as we know it is subject to a lot of factors just now, one being the lack of investment money.
Readers, please do your own research before investing. I am not a financial advisor.
Gerry
- Forums
- ASX - By Stock
- KZA
- estimates and market values
estimates and market values
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online